163 related articles for article (PubMed ID: 24398820)
41. The effects of anorexic drugs on free-fed rats responding under a second-order FI15-min (FR10:S) schedule for high incentive foods.
Evenden J; Ko T
Behav Pharmacol; 2007 Feb; 18(1):61-9. PubMed ID: 17218798
[TBL] [Abstract][Full Text] [Related]
42. Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.
Gary-Bobo M; Elachouri G; Gallas JF; Janiak P; Marini P; Ravinet-Trillou C; Chabbert M; Cruccioli N; Pfersdorff C; Roque C; Arnone M; Croci T; Soubrié P; Oury-Donat F; Maffrand JP; Scatton B; Lacheretz F; Le Fur G; Herbert JM; Bensaid M
Hepatology; 2007 Jul; 46(1):122-9. PubMed ID: 17526015
[TBL] [Abstract][Full Text] [Related]
43. Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats.
DiPatrizio NV; Simansky KJ
J Neurosci; 2008 Sep; 28(39):9702-9. PubMed ID: 18815256
[TBL] [Abstract][Full Text] [Related]
44. Pre-exposure to environmental cues predictive of food availability elicits hypothalamic-pituitary-adrenal axis activation and increases operant responding for food in female rats.
Cifani C; Zanoncelli A; Tessari M; Righetti C; Di Francesco C; Ciccocioppo R; Massi M; Melotto S
Addict Biol; 2009 Sep; 14(4):397-407. PubMed ID: 19413564
[TBL] [Abstract][Full Text] [Related]
45. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.
Bensaid M; Gary-Bobo M; Esclangon A; Maffrand JP; Le Fur G; Oury-Donat F; Soubrié P
Mol Pharmacol; 2003 Apr; 63(4):908-14. PubMed ID: 12644592
[TBL] [Abstract][Full Text] [Related]
46. Opioidergic and dopaminergic modulation of cost/benefit decision-making in Long Evans Rats.
Morales I; Currie PJ; Hackenberg TD; Pastor R
Physiol Behav; 2017 Oct; 179():442-450. PubMed ID: 28716608
[TBL] [Abstract][Full Text] [Related]
47. Effects of a glucosidase inhibitor (acarbose, BAY g 5421) on the development of obesity and food motivated behavior in Zucker (fafa) rats.
Vasselli JR; Haraczkiewicz E; Maggio CA; Greenwood MR
Pharmacol Biochem Behav; 1983 Jul; 19(1):85-95. PubMed ID: 6622510
[TBL] [Abstract][Full Text] [Related]
48. Chronic treatment with the cannabinoid 1 antagonist rimonabant altered vasoactive cyclo-oxygenase-derived products on arteries from obese Zucker rats.
Mingorance C; de Sotomayor MA; Marhuenda E; Herrera MD
J Cardiovasc Pharmacol; 2010 Nov; 56(5):560-9. PubMed ID: 20729749
[TBL] [Abstract][Full Text] [Related]
49. Effects of rimonabant, a cannabinoid CB1 receptor ligand, on energy expenditure in lean rats.
Kunz I; Meier MK; Bourson A; Fisseha M; Schilling W
Int J Obes (Lond); 2008 May; 32(5):863-70. PubMed ID: 18253160
[TBL] [Abstract][Full Text] [Related]
50. Cannabinoid receptor-1 signaling contributions to sign-tracking and conditioned reinforcement in rats.
Bacharach SZ; Nasser HM; Zlebnik NE; Dantrassy HM; Kochli DE; Gyawali U; Cheer JF; Calu DJ
Psychopharmacology (Berl); 2018 Oct; 235(10):3031-3043. PubMed ID: 30109373
[TBL] [Abstract][Full Text] [Related]
51. The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.
Thornton-Jones ZD; Kennett GA; Benwell KR; Revell DF; Misra A; Sellwood DM; Vickers SP; Clifton PG
Pharmacol Biochem Behav; 2006 Jun; 84(2):353-9. PubMed ID: 16814374
[TBL] [Abstract][Full Text] [Related]
52. Selection of a palatable dietary option is not preferentially reduced by cannabinoid CB1 receptor antagonist AM251 in female C57Bl/6J mice.
Mathes CM; Ferrara M; Rowland NE
Pharmacol Biochem Behav; 2009 Nov; 94(1):119-23. PubMed ID: 19660493
[TBL] [Abstract][Full Text] [Related]
53. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940).
Ward SJ; Dykstra LA
Behav Pharmacol; 2005 Sep; 16(5-6):381-8. PubMed ID: 16148442
[TBL] [Abstract][Full Text] [Related]
54. Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats.
Ward SJ; Lefever TW; Rawls SM; Whiteside GT; Walker EA
Psychopharmacology (Berl); 2009 Sep; 206(1):155-65. PubMed ID: 19575185
[TBL] [Abstract][Full Text] [Related]
55. The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets.
Getty-Kaushik L; Richard AM; Deeney JT; Krawczyk S; Shirihai O; Corkey BE
Obesity (Silver Spring); 2009 Oct; 17(10):1856-60. PubMed ID: 19644453
[TBL] [Abstract][Full Text] [Related]
56. Adiponectin is required to mediate rimonabant-induced improvement of insulin sensitivity but not body weight loss in diet-induced obese mice.
Migrenne S; Lacombe A; Lefèvre AL; Pruniaux MP; Guillot E; Galzin AM; Magnan C
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R929-35. PubMed ID: 19211723
[TBL] [Abstract][Full Text] [Related]
57. Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats.
Janiak P; Poirier B; Bidouard JP; Cadrouvele C; Pierre F; Gouraud L; Barbosa I; Dedio J; Maffrand JP; Le Fur G; O'Connor S; Herbert JM
Kidney Int; 2007 Dec; 72(11):1345-57. PubMed ID: 17882151
[TBL] [Abstract][Full Text] [Related]
58. Preference for palatable food is reduced by the gamma-hydroxybutyrate analogue GET73, in rats.
Ottani A; Leone S; Vergara FB; Tacchi R; Loche A; Bertolini A
Pharmacol Res; 2007 Apr; 55(4):271-9. PubMed ID: 17240159
[TBL] [Abstract][Full Text] [Related]
59. Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation.
Tallett AJ; Blundell JE; Rodgers JR
Behav Pharmacol; 2007 Nov; 18(7):591-600. PubMed ID: 17912043
[TBL] [Abstract][Full Text] [Related]
60. Cannabinoid effects on behaviors maintained by ethanol or food: a within-subjects comparison.
Ginsburg BC; Lamb RJ
Behav Pharmacol; 2006 May; 17(3):249-57. PubMed ID: 16572003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
